nicole:
  first_name: Nicole
  last_name: De Vries
  email: nicole.de.vries@company.nl
  role: scanner
  follows: 
    - Afamelanotide
    - Alicaforsen
    - Antihemophilic factor (recombinant) Pegylated
    - Asfotase alfa
    - Binimetinib
    - Burosumab
    - Cerliponase alfa
    - Cholic acid
    - Cinacalcet
    - Dapagliflozine
    - Daratumumab
    - Empagliflozin
    - Etirinotecan pegol
    - Inotuzumab ozogamicin
    - Lutetium-177
    - Nivolumab
    - Paclitaxel
    - Remedium
daisy:
  first_name: Daisy
  last_name: Duell
  email: dduell@zinl.nl
  role: scanner
  follows: 
    - Afamelanotide
    - Alicaforsen
    - Antihemophilic factor (recombinant) Pegylated
    - Asfotase alfa
    - Binimetinib
    - Burosumab
    - Cerliponase alfa
    - Cholic acid
    - Cinacalcet
    - Dapagliflozine
    - Daratumumab
    - Empagliflozin
    - Etirinotecan pegol
    - Inotuzumab ozogamicin
    - Lutetium-177
    - Nivolumab
    - Paclitaxel
    - Remedium
wytse:
  first_name: Wytse
  last_name: Bruinsma
  email: wbruinsma@zinl.nl
  role: scanner
  follows: 
    - Nivolumab
    - Remedium
devi:
  first_name: Devi
  last_name: Donders
  email: devidonders@zinl.nl
  role: workgroup-member
  follows: 
    - Nivolumab
    - Remedium
nikos:
  first_name: Nikos
  last_name: Papadopoulus
  email: nikospapadopoulus@werkgroep.nl
  role: workgroup-member
  domain: Metabolism and Endocrinology
astrid:
  first_name: Astrid
  last_name: Arend
  email: astridarend@roche.nl
  role: manufacturer
riwka:
  first_name: Riwka
  last_name: Rubinstein
  email: rrubinstein@zinl.nl
  role: administrator
achmed:
  first_name: Achmed
  last_name: Ali
  email: achmedali@vws.nl
  role: bystander
  follows: 
    - Afamelanotide
    - Alicaforsen
    - Antihemophilic factor (recombinant) Pegylated